Pipeline Watch: 10 Approvals And Four Phase III Trial Starts
Executive Summary
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
You may also be interested in...
Executives On The Move: Candel Therapeutics, Technoderma Medicines And More
Recent executive changes in the industry include C-suite moves at Bluebird Bio and Jounce Therapeutics. Meanwhile, new directors were appointed at Candel Therapeutics and Technoderma Medicines.
Pipeline Watch: Six New Approvals And 20 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Amicus Therapeutics, Perrigo and More
Recent executive moves in the industry include C-suite changes at Amicus Therapeutics and Assembly Biosciences. Meanwhile, new directors were appointed at Torrent Pharmaceuticals and Perrigo, among others.